insitro, a Casdin/ARCH/GV investment, is a data-driven drug discovery and development company using machine learning and computation at scale to transform the way that drugs are discovered and developed for patients.
In 2022, Occam recruited Martha Rook, PhD to be Chief Technical Operations Officer of insitro. Martha is an experienced industry leader who brings more than 20 years of academic and industry experience in molecular biology, diagnostics development, biologics process development and cell and gene therapy manufacturing.
